Abstract:ABSTRACT An inherent problem in the diagnostic PCR assay is the presence of ill-defined inhibitors of amplification which may cause false-negative results. Addition of an amplifiable fragment of foreign DNA in the PCR to serve as a hybrid internal control (HIC) would allow for a simple way to identify specimens containing inhibitors. Two oligonucleotide hybrid primers were synthesized to contain nucleic acid sequences of the Chlamydia pneumoniae 16S rRNA primers in a position flanking two primers that target the sequences of a 650-bp lambda phage DNA segment. By using the hybrid primers, hybrid DNA comprising a large sequence of lambda phage DNA flanked by short pieces of chlamydia DNA was subsequently generated by PCR, cloned into a plasmid vector, and purified. Plasmids containing the hybrid DNA were diluted and used as a HIC by adding them to each C. pneumoniae PCR test. Consequently, C. pneumoniae primers were able to amplify both chlamydia DNA and the HIC DNA. The production of a 689-bp HIC DNA band on an acrylamide gel indicated that the specimen contained no inhibitors and that internal conditions were compatible with PCR. Subsequently, a biotinylated RNA probe for the HIC was transcribed from a nested sequence of the HIC and was used for its hybridization. Detection of the HIC DNA-RNA hybrid was achieved by enzyme immunoassay (EIA). This PCR-EIA system with a HIC was initially tested with 12 previously PCR-positive and 14 previously PCR-negative specimens. Of the 12 PCR-positive specimens, 11 were reconfirmed as positive; 1 had a negative HIC value, indicating inhibition. Of the 14 previously PCR-negative specimens, 13 were confirmed as true negative; 1 had a negative HIC value, indicating inhibition. The assay was then used with 237 nasopharyngeal specimens from patients with pneumonia. Twenty-one of 237 (8.9%) were positive for C. pneumoniae , and 42 (17.7%) were found to inhibit the PCR. Specimens showing inhibitory activity were diluted 1:10 and were retested. Ten specimens were still inhibitory to the PCR and required further DNA purification. No additional positive samples were detected and 3 nasopharyngeal specimens remained inhibitory to PCR. Coamplification of a HIC DNA can help confirm true-negative PCR results by ruling out the presence of inhibitors of DNA amplification.

Cpn0809 gene: another useful target for detection of Chlamydophila pneumoniae by PCR

A One-Pot, One-Step CRISPR Platform (Crispr-One) for Nucleic Acid Detection: Application for the Detection of Mycoplasma Pneumoniae

ERA-CRISPR/Cas12a-based, fast and specific diagnostic detection for Chlamydia pneumoniae

Detection of Mycoplasma pneumoniae in different respiratory specimens

Preliminary Application of Recombinant Protein of Chlamydiai Protease-like Activity Factor from Chlamydia Pneumoniae in Laboratory Diagnosis

Assessment of Polymerase Chain Reaction and Serology for Detection of Chlamydi a Pneumoniae in Patients with Acute Respiratory Tract Infection

Use of Lambda Phage DNA as a Hybrid Internal Control in a PCR-Enzyme Immunoassay To Detect Chlamydia pneumoniae

Ultrasensitive, Specific, and Rapid Detection of Mycoplasma pneumoniae Using the ERA/CRISPR–Cas12a Dual System

Clinical value of recombinant protein of chlamydial protease-like activity factor from Chlamydia pneumoniae in serodiagnosis

Establishment of PCR assay for detecting mycoplasma suis

CHAMP: A Centrifugal Microfluidics-Based CRISPR/Cas12b-Combined Real-Time LAMP One-Pot Method for Mycoplasma pneumoniae Infection Diagnosis

Amplification of P1 gene by polymerase chain reaction for detection of Mycoplasma pneumoniae

Establishment and Application of a Real-time , Duplex PCR Method for Simultaneous Detection of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis

Improved Targeting of the 16S Rdna Nanopore Sequencing Method Enables Rapid Pathogen Identification in Bacterial Pneumonia in Children.

Clinical Evaluation of a New Single-Tube Multiplex Reverse Transcription PCR Assay for Simultaneous Detection of 11 Respiratory Viruses, Mycoplasma Pneumoniae and Chlamydia in Hospitalized Children with Acute Respiratory Infections

Evaluation of the FPMC respiratory panel for detection of respiratory tract pathogens in nasopharyngeal swab and sputum specimens

CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia

A method for rapid detection of Mycoplasma pneumoniae and its macrolide resistance mutation

PCR identification of four medically important Candida species by using a single primer pair

Application of a nested polymerase chain reaction assay to detect Mycoplasma hyopneumoniae from nasal swabs

Evaluation of a multiplex PCR assay for detection of respiratory viruses and Mycoplasma pneumoniae in oropharyngeal swab samples from outpatients